“About 25 percent of patients with low back pain actually suffer from SI joint dysfunction,” said Michael Oh, MD, chief of the division of functional neurosurgery at Allegheny General Hospital. “While it’s difficult to diagnose, once it’s identified, it can generally be treated very successfully.”
Dr. Oh was a principal investigator of a clinical trial at Allegheny General Hospital comparing patients who undergo surgical treatment with iFuse to those who rely on conservative care.
More articles on spine orthopedic devices:
Medtronic CEO sells 20k shares for $1.52M: 5 key points
OsteoRemedies appoints Eric Stookey COO
DOJ extends Biomet’s deferred prosecution agreement
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
